Overview
- 94 inspections across 90 sites are on record.
- 114 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-27.
At a glance
Inspections
94
Sites
90
Observations
114
Career since
Jun 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| RK Pharma Inc. | 27 Mar 2026 | Human Drugs | On file |
| Chartwell Pharmaceuticals Congers, LLC | 18 Nov 2025 | Human Drugs | View 483 → |
| RK Pharma Inc. | 28 Aug 2025 | Human Drugs | On file |
| Elite Laboratories Inc. | 1 Aug 2025 | Human Drugs | On file |
| Unipack LLC | 30 Jun 2025 | Human Drugs | On file |
Sites inspected
RK Pharma Inc.Pearl River, United States2 insp.
Chartwell Pharmaceuticals Congers, LLCCongers, United States1 insp.
Elite Laboratories Inc.Northvale, United States1 insp.
Unipack LLCSouth Plainfield, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jogy George9 shared
Unnee Ranjan9 shared
Emmanuel J Ramos5 shared
Stacie A Woods3 shared
Niketa Patel3 shared
Helen Verdel2 shared
Logan T Williams2 shared
Arsen Karapetyan2 shared
Yvins Dezan2 shared
Jessica S Estriplet2 shared
Full investigator report
Get the verbatim findings behind Lata C Mathew's 114 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site